Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.9K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.9K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K
Hemoglobin01:24

Hemoglobin

10.0K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
10.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

1.0K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

8.5K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
8.5K
Multiple Allele Traits01:49

Multiple Allele Traits

38.9K
The Concept of Multiple Allelism
38.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sickle cell disease].

Der Internist·2020
Same author

[Anemia and hemoglobin diseases in patients with migration background].

Deutsche medizinische Wochenschrift (1946)·2014
Same author

Newly diagnosed immune thrombozytopenia--German guideline concerning initial diagnosis and therapy.

Klinische Padiatrie·2012
Same author

[Problems of adult sickle cell patients in Germany].

Deutsche medizinische Wochenschrift (1946)·2009
Same author

Haemoglobinopathies and newborn haemoglobinopathy screening in Germany.

Journal of clinical pathology·2008
Same author

Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.

British journal of haematology·2007
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Related Experiment Video

Updated: Apr 9, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K

[Hemoglobin disorders].

R Dickerhoff1

  • 1Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immunologie, Universität Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland, roswitha.dickerhoff@med.uni-duesseldorf.de.

Der Internist
|June 19, 2015
PubMed
Summary
This summary is machine-generated.

Hemoglobin disorders, including thalassemias and sickle cell disease, are present in Germany due to immigration. Early screening for asymptomatic carriers is crucial to prevent hereditary diseases in newborns.

More Related Videos

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

10.5K
Measuring Deformability and Red Cell Heterogeneity in Blood by Ektacytometry
09:12

Measuring Deformability and Red Cell Heterogeneity in Blood by Ektacytometry

Published on: January 12, 2018

15.7K

Related Experiment Videos

Last Updated: Apr 9, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

10.5K
Measuring Deformability and Red Cell Heterogeneity in Blood by Ektacytometry
09:12

Measuring Deformability and Red Cell Heterogeneity in Blood by Ektacytometry

Published on: January 12, 2018

15.7K

Area of Science:

  • Genetics
  • Hematology
  • Public Health

Context:

  • Hemoglobin disorders, such as thalassemias and sickle cell disease, have been identified in Germany.
  • Their prevalence increased following immigration from endemic regions starting in the 1950s.
  • These genetic conditions necessitate complex medical management.

Purpose:

  • To highlight the presence and implications of hemoglobin disorders in Germany.
  • To emphasize the need for carrier screening to prevent transmission.
  • To inform healthcare providers about their role in managing these hereditary diseases.

Summary:

  • Hereditary hemoglobin disorders, including thalassemias and sickle cell disease, are found in Germany.
  • These conditions require sophisticated treatment protocols.
  • Screening for asymptomatic carriers is essential for genetic counseling and preventing affected offspring.

Impact:

  • Increased awareness among healthcare professionals regarding hemoglobinopathies in Germany.
  • Implementation of carrier screening programs to reduce the incidence of inherited blood disorders.
  • Improved genetic counseling services for at-risk populations.